Insider selling at Universal Health Services, especially by Executive VP Steve Filton, may worry investors. Despite some insider buying, the long-term outlook isn't very positive. High insider ownership suggests management's interests align with shareholders, but insider selling warrants caution.
The declining ROCE trend at Universal Health Services does not inspire confidence. Despite the company's reinvestment in its own business, returns are shrinking. Investors looking for a multi-bagger might want to consider other options.
Universal Health Services is still a bargain according to the price multiple model. Its volatile share price could provide more buying opportunities. The company's optimistic future growth hasn't been fully factored into the share price yet.
Insider selling over the past year may worry shareholders, despite high insider ownership suggesting aligned interests. This activity raises doubts in the company's valuation.
Universal Health Services' trends for ROCE raise concerns due to the lack of significant sales growth or changes in earnings from investment activities. The moderate stock gain may signal investors' uncertainty on future performance.
Six of the world's famous stocks came together to give you direct access to investment insights from our intelligent community! Guess the Stock E57 Answers: Company A: ADBE Company B: SAP Company C: ADSK Market Capitalization comparison: Company A > Company B > Company C Guess the Stock E55 Answers: Company A: HCA Company B: UHS Company C: ENSG Market Capitalization comparison: Company A > Company B > Company C Thank you ALL for joining the Guess t...
Universal Health Services股票討論區
Guess the Stock E57 Answers:
Company A: ADBE
Company B: SAP
Company C: ADSK
Market Capitalization comparison:
Company A > Company B > Company C
Guess the Stock E55 Answers:
Company A: HCA
Company B: UHS
Company C: ENSG
Market Capitalization comparison:
Company A > Company B > Company C
Thank you ALL for joining the Guess t...
2022年利息費用佔營業利潤的13%,2023Q1佔18%,利息負擔比較重。
2023Q1營收增長5.3%,營業利潤增長19.7%,淨利潤則受利息費用暴增影響僅增長了7.5%。
資產負債表5年來從51.4%增長到了55.8%,2023Q1略降到55.3%。
應收賬款和存貨的比例和增速還算正常,商譽39.09億佔59.7億淨資產的65.5%。
長期借款達到了47.3億,佔淨資產的79%,考慮到淨資產中商譽佔比,實際槓桿率很高。
5年來除2021年外,現金流經營淨額均大幅超過投資淨額,股東盈餘較多。
目前市盈率16.5,市盈率TTM略降到16,可以多觀察幾個季度再說。
Gap Ups
1. $Smith & Nephew(SNN.US)$ - up 4.3%
2. $Coherent(COHR.US)$ - up 4.1%
3. $豐田汽車(TM.US)$ - up 3.2%
4. $齊默巴奧米特控股(ZBH.US)$ - up 2.9%
5. $IPG光電(IPGP.US)$ - up 2.8%
6. $史賽克(SYK.US)$ - up 2.8%
7. $Universal Health Services(UHS.US)$ - up 2....
Gap Ups
1. $SAP SE(SAP.US)$ - up 3.2%
2. $費森尤斯醫療(FMS.US)$ - up 3.1%
3. $HCA醫療(HCA.US)$ - up 2.2%
4. $寶潔(PG.US)$ - up 2.1%
5. $諾和諾德(NVO.US)$ - up 1.5%
6. $Alcon(ALC.US)$ - up 1.2%
7. $CyberArk(CYBR.US)$ - up 1.0%
8. $阿卡迪亞醫療保健(ACHC.US)$ - up 0.9%...
暫無評論